| Lauren Williams, | |
|
1047 Union University Dr, Jackson, TN 38305-3655 | |
| (731) 256-0035 | |
| Not Available |
| Full Name | Lauren Williams |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 1047 Union University Dr, Jackson, Tennessee |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013454735 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 22189 (Tennessee) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Lauren Williams, 1047 Union University Dr, Jackson, TN 38305-3655 Ph: () - | Lauren Williams, 1047 Union University Dr, Jackson, TN 38305-3655 Ph: (731) 256-0035 |
News Archive
Teva Pharmaceutical Industries Ltd. announced today enrollment of the first patient in the MODERATO study - a Phase IV clinical study designed to evaluate the effect of AZILECT (rasagiline tablets) on cognitive function in adults with mild cognitive impairment (MCI) in Parkinson's disease (PD-MCI).
Researchers from the Indiana University School of Medicine and the Purdue School of Science at Indiana University-Purdue University Indianapolis have created the first three-dimensional image of how a well-established chemotherapy agent targets and binds to DNA.
Researchers have discovered a surprise lurking inside mitochondria, the power plants that are present in every cell. It turns out that these powerhouses also contain a protein that triggers the immune system to attack viral invaders.
Allos Therapeutics, Inc. today announced the presentation of favorable survival data from the Company's international, randomized Phase 2b investigational study of FOLOTYN relative to erlotinib in patients with Stage IIIB/IV (advanced) non-small cell lung cancer (NSCLC). In this study, patients receiving FOLOTYN had a 16 percent reduction in the risk of death compared to erlotinib in the overall (intent-to-treat) population.
Scientists used genetic sequencing to discover new evidence that the first vaccine shown to prevent HIV infection in people also affected the viruses in those who did become infected. Viruses with two genetic "footprints" were associated with greater vaccine efficacy. The results were published today in the online edition of the journal Nature.
› Verified 4 days ago
Katherine E Wyatt, A.P.R.N. Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 145 Innovation Dr, Jackson, TN 38305 Phone: 731-422-0213 Fax: 731-660-8301 | |
Amy K Lawrence, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2863 Highway 45 Byp, Jackson, TN 38305 Phone: 731-422-0213 Fax: 731-660-8380 | |
Anna K Younger, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 145 Innovation Dr, Jackson, TN 38305 Phone: 731-422-0213 Fax: 731-660-8301 | |
Kirsten Siler, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 27a Medical Center Drive, Jackson, TN 38301 Phone: 731-541-3310 | |
Stephanie Pool, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 36 Pemberton Cv, Jackson, TN 38305 Phone: 731-394-1145 Fax: 844-374-0233 | |
Kimberlie A Simpson, APRN, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 23 Independence Ln, Jackson, TN 38305 Phone: 731-617-1483 |